NeoGenomics appoints Carolyn Starrett, former Flatiron Health CEO, to board

NEOGENOMICS INC

Board expanded from 9 to 10 directors; Starrett fills new seat effective June 23, 2026.
Starrett brings 25+ years experience in data/tech, AI, and cancer care; was CEO of Flatiron Health from 2021-2025.
She will serve until 2027 annual meeting; compensation per standard director program.
Chair Lynn Tetrault cites Starrett's expertise in real-world data and analytics for cancer care.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.